• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    Imprimis Pharmaceuticals, Inc. (IMMY)

    -NasdaqCM
    7.94 Up 0.11(1.40%) Mar 4, 3:59PM EST
    Add to Portfolio
    Prev Close:7.83
    Open:7.78
    Bid:7.62 x 500
    Ask:7.99 x 900
    1y Target Est:12.50
    Beta:-0.42
    Next Earnings Date:N/A
    Day's Range:7.78 - 7.97
    52wk Range:4.71 - 9.24
    Volume:1,330
    Avg Vol (3m):11,202
    Market Cap:73.48M
    P/E (ttm):N/A
    EPS (ttm):-1.02
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMY

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):65.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.08
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Imprimis Pharmaceuticals, Inc. operates as a specialty pharmaceutical company focusing on the commercial development of compounded drug formulations. The company, through a strategic relationship with Professional Compounding Centers of America, I... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback